Abstract:OBJECTIVE:To investigate the relationship between plasma homocysteine (Hcy) and cognitive impairment so as to provide basis for dementia prevention.METHODS:Subjects at high risk for stroke were selected from the Screening and Prevention Program of Stroke (organized by the Ministry of Health, from August to December, 2012) in Yanta area, Xi'an. Fasting blood was taken from cubital vein to measure Hcy. When Hcy>15 µmol/L was defined as hyperhomocysteinemia, Hcy in the range of 16-30 µ mol/L was considered mild, ≥ 31 µ mol/L as moderate-severe hyperhomocysteinemia. The cognitive function was evaluated by the Mini Mental State Examination (MMSE). MMSE grades under normal value were defined as cognitive impairment.RESULTS:393 subjects were randomly recruited, including 173 men (44.0%) and 220 women (56.0%). Number of cases with cognitive impairment was 70 (17.8% of the total subjects), with hyperhomocysteinemia was 220 (56.0% of the total subjects). The prevalence of cognitive impairment did not show significant difference with hyperhomocysteinemia or normal Hcy group (16.8% vs. 19.1%, P>0.05), neither with mild and moderate-severe hyperhomocysteinemia group (17.0% vs. 16.3% , P > 0.05). Results from Spearman correlation analysis indicated that there was no correlation between MMSE grades and Hcy (rs = -0.01, P = 0.85). Prevalence of cognitive impairment in the smoking group was higher than that in the non-smoking group (21.3% vs. 7.8%, P < 0.01), but higher in hypertension group than that in the normal blood pressure group (21.7% vs. 8.0%, P < 0.01). In the stroke group, prevalence of cognitive impairment was seen higher than that in the non-stroke group (25.3% vs. 15.4%, P < 0.05). Based on the results from Binary logistic regression, cognitive impairment appeared to be associated with the levels of education (OR = 0.90, 95% CI:0.81-0.98, P = 0.02), histories of hypertension (OR = 1.02, 95%CI:1.01-1.04, P = 0.01) and stroke(OR = 1.86, 95%CI:1.04-3.33, P = 0.04), but there was no correlation seen between Hcy and cognitive impairment (OR = 0.90, 95% CI:0.51-1.58, P = 0.71).CONCLUSION:Plasma homocysteine did not seem a risk factor for cognitive impairment.

Hypermethylation of ERа-A gene and high serum homocysteine level are correlated with cognitive impairment in white matter hyperintensity patients

Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia

Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults

Genome-wide analysis of DNA methylation and its relationship with serum homocysteine levels in patients with hypertension.

APOE Genotype-specific Methylation Patterns are Linked to Alzheimer Disease Pathology and Estrogen Response

[Investigation on Plasma Homocysteine Level and Cognition in Population at High Risk for Stroke in Xi'an].

DNA Methylation at C-Reactive Protein-Associated CpG Sites May Mediate the Pathway Between Educational Attainment and Cognition

Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: Moderated by brain cortical thickness

Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting Mild Cognitive Impairment in Parkinson's Disease

Homocysteine, white matter hyperintensities, and cognition in healthy elderly people

Relationship of Plasma Homocysteine and the Gene Polymorphisms of Metabolic Enzymes with Alzheimer's Disease

Cerebral small vessel disease mediates the association between homocysteine and cognitive function

Homocysteine Altered Gyrification Related to Self‐awareness of Everyday Cognition

Hyperhomocysteinemia in Alzheimer dementia patients and cognitive decline after 6 months follow-up period

Relationship between High Homocysteine Levels in Serum and Cognitive Impairment of Patients with Parkinson′ s Disease

Associations between DNA methylation and cognitive function in early-stage hormone receptor-positive breast cancer patients

Epigenome-wide DNA methylation analysis of late-stage mild cognitive impairment

GENOME-WIDE DNA METHYLATION ANALYSIS IDENTIFIES SERUM HOMOCYSTEINE-ASSOCIATED CPG SITES IN HYPERTENSIVES

Association of serum cystatin C with white matter abnormalities in patients with amnestic mild cognitive impairment

Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD)

Hyperhomocysteinemia can predict the severity of white matter hyperintensities in elderly lacunar infarction patients